Login / Signup

Cytogenetic Subclone Burden: A New Biomarker Predicting Chronic Lymphocytic Leukemia Patients Outcome.

Salah ArefMona MansourSherin Abdel-AzizMohamed SabryMohamed ArefWesam El Dosoky
Published in: Asian Pacific journal of cancer prevention : APJCP (2024)
Quantification of 17pdel burden (>vs.≤33%) could be used for refining risk stratification of CLL patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • risk factors